Lv31
320 积分 2022-09-11 加入
Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells
22分钟前
待确认
Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis
1小时前
已完结
An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation
5小时前
已完结
Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors
8小时前
已完结
Endoscopy in inflammatory bowel disease: what every endoscopist should know
4天前
已完结
Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis
6天前
已完结
Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease
7天前
已完结
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
9天前
已完结
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX
9天前
已完结
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease
10天前
已完结
皖公网安备34019202002308
